Not a scam, but yes think we will see lower. A proven drug that worked in a Phase 2 study in a different delivery method unexpectedly failed a Phase 3 study although the results were mixed and need further analysis to draw definitive conclusions. As this is company's only drug, definitely a gamble, could pay off big time if it ends up working, but if it doesn't will end in bankruptcy. Think we will see lower before any potential upside.
News 
Market Data 
Discover 
